ENTACAPONE for Therapeutic response shortened: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where ENTACAPONE was used for Therapeutic response shortened.
Most Reported Side Effects for ENTACAPONE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Dyskinesia | 266 | 18.7% | 37 | 113 |
| Parkinson's disease | 138 | 9.7% | 12 | 49 |
| Fall | 114 | 8.0% | 26 | 62 |
| Hallucination | 104 | 7.3% | 9 | 47 |
| Dysphagia | 93 | 6.5% | 7 | 45 |
| Therapeutic response shortened | 90 | 6.3% | 0 | 62 |
| Somnolence | 84 | 5.9% | 7 | 18 |
| Tremor | 82 | 5.8% | 4 | 21 |
| Gait disturbance | 79 | 5.6% | 3 | 26 |
| Hallucination, visual | 79 | 5.6% | 6 | 41 |
| Dystonia | 77 | 5.4% | 0 | 50 |
| Confusional state | 76 | 5.3% | 20 | 32 |
| Orthostatic hypotension | 75 | 5.3% | 18 | 52 |
| Psychotic disorder | 70 | 4.9% | 2 | 57 |
| Drug ineffective | 65 | 4.6% | 6 | 12 |
Other Indications for ENTACAPONE
Parkinson's disease (904)
Product used for unknown indication (305)
Parkinsonism (36)
Drug effect decreased (16)
Psychotic disorder (15)
Fall (8)
Gait disturbance (8)
Product administration error (7)